Resources

Transition from NDA to Biosimlars and FDA guidance on biosimilar Naming

Speaker
9/28/2016
Hotel Hilton, (Andheri East)
Mumbai,
India
Transition from NDA to Biosimlars and FDA guidance on biosimilar Naming